Dr. Thomas Andrew Makin, MD

Dr. Makin practices at Allegheny Professional Building in Pittsburgh, Pennsylvania.

Dr. Makin's NPI, 1215426499, was assigned on May 3, 2018. Dr. Makin graduated from Jacobs School of Medicine and Biomedical Sciences in 2018. Dr. Makin holds Virginia license 0101276952.

Dr. Makin's primary practice is Allegheny Professional Building, at 490 E North Ave, Pittsburgh, PA 15212 in Allegheny County. The practice phone is (412) 330-5861.

Dr. Makin's primary practice is Allegheny Professional Building in Pittsburgh, Pennsylvania. Dr. Makin is also affiliated with Allegheny General Hospital. The medical group on file is AHN Primary Care - Family Med Associates at H+W Pavilion Bethel Park. Dmand AI also links Dr. Makin to 1 more hospital and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Makin practices, 3 sites in all. Vendor and product names are available with a free account.

Allergy and immunology is Dr. Makin's primary specialty in the NPI Registry, under taxonomy code 207K00000X. Dr. Makin is board certified in allergy & immunology by the American Board of Allergy and Immunology. Dmand AI has Dr. Makin's licenses on file in 2 states: Virginia and Pennsylvania.

Dmand AI lists asthma, chronic nasal allergies and immune deficiency disease among the conditions Dr. Makin treats.

CMS data shows 23,399 Medicare services from Dr. Makin across 16 procedure codes in 2024, for 445 Medicare patients. Medicare paid $364,195 for them. Every service was in an office.

CMS counts 445 Medicare patients who saw Dr. Makin in 2024. The largest group is 65 to 74, with 260 patients. 75% of them have high cholesterol, and 72% have high blood pressure. 3% are also on Medicaid. Their average risk score is 0.91, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Makin's median patient age at 39, with 65% women.

In 2024, Dr. Makin wrote 458 Medicare Part D claims for 128 patients. 61% of them were for generic drugs. CMS names the drug for 326 of them, across 15 drugs with 11 or more claims each, at $139,490 in total drug cost. In 2023, CMS named 48 claims across 4 drugs.

Dr. Makin accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 7 papers to Dr. Makin, published from 2014 to 2025. The most frequent topics are Agammaglobulinemia, Immunoglobulin E and Immunoglobulin G. Dr. Makin has published most often in Ann Allergy Asthma Immunol. Dr. Makin's most frequent co-authors are Monica G. Lawrence, MD, Florence Ida Hsu, MD and Insoo Kang, MD.

CMS Open Payments shows 132 general payments to Dr. Makin from 22 drug and device companies from 2023 to 2025. Food and beverage make up the largest share, 99% of the total. AstraZeneca Pharmaceuticals LP paid the most, $1,026.

Dr. Makin graduated from Jacobs School of Medicine and Biomedical Sciences in 2018. Dr. Makin is a member of AOA, AAAAI and ACAAI.